John Haurum, the former chief executive of F-star Biotechnology Ltd, has joined NeoPhore Ltd as a non-executive director to help oversee the company’s immunotherapy programme. Dr Haurum, who obtained a medical degree and MSc in immunology from Aarhus University in Denmark, is a former head of research at ImClone Systems and former chief scientific officer and co-founder of Symphogen A/S, a Danish antibody company. He earned a DPhil in immunology from the University of Oxford, UK.
NeoPhore announced the appointment on 20 March 2019.
Copyright 2019 Evernow Publishing